In Vitro Inhibition of Human Carbonic Anhydrase I and II Isozymes with Natural Phenolic Compounds
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Inhibition of Human Carbonic Anhydrase I and II Isozymes with Natural Phenolic Compounds
Authors
Keywords
-
Journal
Chemical Biology & Drug Design
Volume 77, Issue 6, Pages 494-499
Publisher
Wiley
Online
2011-02-19
DOI
10.1111/j.1747-0285.2011.01104.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I–XIV with a series of natural product polyphenols and phenolic acids
- (2010) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I–XV
- (2010) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Carbonic Anhydrase Inhibitors: Inhibition of Human Erythrocyte Isozymes I and II with a Series of Phenolic Acids
- (2010) S. Beyza Öztürk Sarıkaya et al. Chemical Biology & Drug Design
- Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols
- (2009) Murat Şentürk et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I–XIV
- (2009) T. Abdülkadir Coban et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Carbonic anhydrase inhibitors: Two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1,2-α-dithienylethene derivatives
- (2009) Daniel Vomasta et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antioxidant properties of resveratrol: A structure–activity insight
- (2009) İlhami Gülçin Innovative Food Science & Emerging Technologies
- The effect of ethanol on erythrocyte carbonic anhydrase isoenzymes activity: An in vitro and in vivo study
- (2009) T. Abdulkadir Çoban et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Inhibition of Carbonic Anhydrase II by Thioxolone: A Mechanistic and Structural Study†
- (2008) Albert A. Barrese et al. BIOCHEMISTRY
- In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II
- (2008) Esra Bayram et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Carbonic anhydrase inhibitors: Inhibition of mammalian isoforms I–XIV with a series of substituted phenols including paracetamol and salicylic acid
- (2008) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Carbonic anhydrase inhibitors: Thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?
- (2008) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols
- (2008) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Carbonic anhydrase inhibitors: Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I–XIV)
- (2008) Alessio Innocenti et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antioxidant and radical scavenging properties of curcumin
- (2008) Tuba Ak et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Design of Zinc Binding Functions for Carbonic Anhydrase Inhibitors
- (2008) Jean-Louis Montero et al. CURRENT PHARMACEUTICAL DESIGN
- Diuretics: From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the Sulfonamides
- (2008) Claudiu Supuran CURRENT PHARMACEUTICAL DESIGN
- Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes
- (2008) Mika Hilvo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In vitroantioxidant activity of silymarin
- (2008) Ekrem KÖksal et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started